Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    18809614 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients
Condition: NSCLC
Intervention:
2 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)
3 Recruiting Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma
Condition: Stage Ib Lung Carcinoma
Intervention: Drug: vinorelbine plus cisplatin
4 Recruiting Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab
5 Unknown  To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer
Conditions: Thoracic Neoplasms;   Non-small Cell Lung Cancer
Intervention: Radiation: 3D conform radiotherapy

Study has passed its completion date and status has not been verified in more than two years.